Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

CLAD Deconvolved PERG Responses in Glaucoma Patients

NCT06388096 is registered in ClinicalTrials.gov with Jorvec Corp. as lead sponsor.

NCT NCT06388096
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06388096 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
CLAD Deconvolved PERG Responses in Glaucoma Patients
Lead sponsor
Jorvec Corp.
Phase
Not applicable
Overall status
Unknown status
Start date
June 1, 2023
Completion date
June 1, 2025
Enrollment
120 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

glaucoma, suspect